Chronic cough: new insights and future prospects
Chronic cough is defined in adults as a cough that lasts for ≥8 weeks. When it proves intractable to standard-of-care treatment, it can be referred to as refractory chronic cough (RCC). Chronic cough is now understood to be a condition of neural dysregulation. Chronic cough and RCC result in a serio...
Main Authors: | Alyn Morice, Peter Dicpinigaitis, Lorcan McGarvey, Surinder S. Birring |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2021-12-01
|
Series: | European Respiratory Review |
Online Access: | http://err.ersjournals.com/content/30/162/210127.full |
Similar Items
-
Treating acute cough: wet versus dry – have we got the paradigm wrong?
by: Alyn H. Morice, et al.
Published: (2015-10-01) -
From bench to bedside: The role of cough hypersensitivity in chronic cough
by: Matthew G. Drake, et al.
Published: (2023-08-01) -
Design and rationale of two phase 3 randomised controlled trials (COUGH-1 and COUGH-2) of gefapixant, a P2X3 receptor antagonist, in refractory or unexplained chronic cough
by: David R. Muccino, et al.
Published: (2020-11-01) -
Recent progress in the management of chronic cough
by: Woo-Jung Song, et al.
Published: (2020-07-01) -
The P2X3 receptor antagonist filapixant in patients with refractory chronic cough: a randomized controlled trial
by: Christian Friedrich, et al.
Published: (2023-04-01)